Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BOSTOM AG' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 83 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Liaugaudas, G; Jacques, PF; Selhub, J; Rosenberg, IH; Bostom, AG
      Renal insufficiency, vitamin B-12 status, and population attributable riskfor mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    2. Friedman, AN; Bostom, AG; Selhub, J; Levey, AS; Rosenberg, IH
      The kidney and homocysteine metabolism

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    3. Shemin, D; Bostom, AG; Selhub, J
      Treatment of hyperhomocysteinemia in end-stage renal disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    4. Shemin, D; Bostom, AG; Laliberty, P; Dworkin, LD
      Residual renal function and mortality risk in hemodialysis patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    5. Bostom, AG
      Effects of fenofibrate and gemfibrozil on plasma homocysteine

      LANCET
    6. Yango, A; Shemin, D; Hsu, N; Jacques, PF; Dworkin, L; Selhub, J; Bostom, AG
      L-folinic acid versus folic acid for the treatment of hyperhomocysteinemiain hemodialysis patients Rapid Communication

      KIDNEY INTERNATIONAL
    7. Bostom, AG; Shemin, D; Gohh, RY; Beaulieu, AJ; Bagley, P; Massy, ZA; Jacques, PF; Dworkin, L; Selhub, J
      Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients

      KIDNEY INTERNATIONAL
    8. Bostom, AG; Kronenberg, F; Jacques, PF; Kuen, E; Ritz, E; Konig, P; Kraatz, G; Lhotta, K; Mann, JFE; Muller, GA; Neyer, U; Riegel, W; Schwenger, V; Riegler, P; Selhub, J
      Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate

      ATHEROSCLEROSIS
    9. Weisberg, IS; Jacques, PF; Selhub, J; Bostom, AG; Chen, ZT; Ellison, RC; Eckfeldt, JH; Rozen, R
      The 129XA -> C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine

      ATHEROSCLEROSIS
    10. Bostom, AG; Kronenberg, F; Gohh, RY; Schwenger, V; Kuen, E; Konig, P; Kraatz, G; Lhotta, K; Mann, JFE; Muller, GA; Neyer, U; Riegel, W; Riegler, P; Ritz, E; Selhub, J
      Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiency

      ATHEROSCLEROSIS
    11. Morris, MS; Bostom, AG; Jacques, PF; Selhub, J; Rosenberg, IH
      Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey

      ATHEROSCLEROSIS
    12. Bostom, AG; Selhub, J; Jacques, PF; Rosenberg, IH
      Power shortage: Clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour

      ANNALS OF INTERNAL MEDICINE
    13. Jacques, PF; Bostom, AG; Wilson, PWF; Rich, S; Rosenberg, IH; Selhub, J
      Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    14. Bostom, AG
      Homocysteine: "Expensive creatinine" or important, modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients?

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    15. Shemin, D; Bostom, AG; Lambert, C; Hill, C; Kitsen, J; Kliger, AS
      Residual renal function in a large cohort of peritoneal dialysis patients:Change over time, impact on mortality and nutrition

      PERITONEAL DIALYSIS INTERNATIONAL
    16. Bostom, AG; Dworkin, LD
      Cystatin C measurement: Improved detection of mild decrements in glomerular filtration rate versus creatinine-based estimates?

      AMERICAN JOURNAL OF KIDNEY DISEASES
    17. Bostom, AG; Garber, C
      Endpoints for homocysteine-lowering trials

      LANCET
    18. Bostom, AG; Shemin, D; Gohh, RY; Beaulieu, AJ; Jacques, PF; Dworkin, L; Selhub, J
      Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients

      TRANSPLANTATION
    19. Bostom, AG; Shemin, D; Bagley, P; Massy, ZA; Zanabli, A; Christopher, K; Spiegel, P; Jacques, PF; Dworkin, L; Selhub, J
      Controlled comparison of 1-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients (vol 101, pg2829, 2000)

      CIRCULATION
    20. Bostom, AG; Shemin, D; Bagley, P; Massy, ZA; Zanabli, A; Christopher, K; Spiegel, P; Jacques, PF; Dworkin, L; Selhub, J
      Controlled comparison of l-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients

      CIRCULATION
    21. Bostom, AG; Bausserman, L; Jacques, PF; Liaugaudas, G; Selhub, J; Rosenberg, IH
      Cystatin C as a determinant of fasting plasma total homocysteine levels incoronary artery disease patients with normal serum creatinine

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    22. Beaulieu, AJ; Gohh, RY; Han, H; Hakas, D; Jacques, PF; Selhub, J; Bostom, AG
      Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renaltransplant recipients

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    23. Shemin, D; Lapane, KL; Bausserman, L; Kanaan, E; Kahn, S; Dworkin, L; Bostom, AG
      Plasma total homocysteine and hemodialysis access thrombosis: A prospective study

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    24. Bostom, AG; Culleton, BF
      Hyperhomocysteinemia in chronic renal disease

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    25. Bostom, AG; Gohh, RY; Bausserman, L; Hakas, D; Jacques, PF; Selhub, J; Dworkin, L; Rosenberg, IH
      Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    26. Bostom, AG; Culleton, B
      Hyperhomocysteinemia in chronic renal disease: Potential relevance to arteriosclerosis

      SEMINARS IN DIALYSIS
    27. Beaulieu, AJ; Lapane, KL; Gohh, RY; Selhub, J; Monaco, AP; Dworkin, L; Rosenberg, IH; Bostom, AG
      Short-term reproducibility of total homocysteine determinations in stable renal transplant recipients

      TRANSPLANTATION PROCEEDINGS
    28. Bostom, AG; Gohh, RY; Beulieu, AJ; Han, H; Jacques, PF; Selhub, J; Dworkin, L; Rosenberg, IH
      Determinants of fasting plasma total homocysteine levels among chronic stable renal transplant recipients

      TRANSPLANTATION
    29. Jacques, PF; Selhub, J; Bostom, AG; Wilson, PWF; Rosenberg, IH
      The effect of folic acid fortification on plasma folate and total homocysteine concentrations

      NEW ENGLAND JOURNAL OF MEDICINE
    30. Bostom, AG; Gohh, RY; Liaugaudas, G; Beaulieu, AJ; Han, H; Jacques, PF; Dworkin, L; Rosenberg, IH; Selhub, J
      Prevalence of mild fasting hyperhomocysteinemia in renal transplant versuscoronary artery disease patients after fortification of cereal grain flourwith folic acid

      ATHEROSCLEROSIS
    31. Bostom, AG; Selhub, J
      Homocysteine and arteriosclerosis - Subclinical and clinical disease associations

      CIRCULATION
    32. Malinow, MR; Bostom, AG; Krauss, RM
      Homocyst(e)ine, diet, and cardiovascular diseases - A statement for healthcare professionals from the Nutrition Committee, American Heart Association

      CIRCULATION
    33. Malinow, MR; Bostom, AG; Krauss, RH
      Homocysteine and cardiovascular diseases - Response

      CIRCULATION
    34. Bostom, AG; Silbershatz, H; Rosenberg, IH; Selhub, J; D'Agostino, RB; Wolf, PA; Jacques, PF; Wilson, PWF
      Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women

      ARCHIVES OF INTERNAL MEDICINE
    35. Bostom, AG; Rosenberg, IH; Silbershatz, H; Jacques, PF; Selhub, J; D'Agostino, RB; Wilson, PWF; Wolf, PA
      Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham Study

      ANNALS OF INTERNAL MEDICINE
    36. BOSTOM AG; SHEMIN D; GOHH RY; VERHOEF P; NADEAU MR; BIANCHI LA; HOPKINSGARCIA BJ; JACQUES PF; SELHUB J; DWORKIN L; ROSENBERG IH
      LOWER FASTING TOTAL PLASMA HOMOCYSTEINE LEVELS IN STABLE RENAL-TRANSPLANT RECIPIENTS VERSUS MAINTENANCE DIALYSIS PATIENTS

      Transplantation proceedings
    37. ROSENBERG IH; BOSTOM AG; SILBERSHATZ H; JACQUES PF; SELHUB J; DAGOSTINO RB; WILSON PWF; WOLF PA
      NONFASTING PLASMA TOTAL HOMOCYSTEINE LEVELS AND STROKE OCCURRENCE IN ELDERLY FRAMINGHAM WOMEN AND MEN - A PROSPECTIVE-STUDY

      Circulation
    38. BOSTOM AG; SILBERSHATZ H; JACQUES PF; SELHUB J; DAGOSTINO RB; WOLF PA; ROSENBERG IH; WILSON PWF
      SERUM TOTAL HOMOCYSTEINE LEVELS PREDICT ALL-CAUSE AND CARDIOVASCULAR-DISEASE MORTALITY IN ELDERLY FRAMINGHAM MEN AND WOMEN

      Circulation
    39. BOSTOM AG; GOHH RY; BEAULIEU A; HUME AL; JACQUES PF; SELHUB J; ROSENBERG IH
      VITAMIN-B6 TREATMENT INDEPENDENTLY REDUCES THE POST-METHIONINE LOAD INCREASE IN TOTAL HOMOCYSTEINE LEVELS - RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED STUDY

      Circulation
    40. BOSTOM AG; SHEMIN D; VERHOEF P; NADEAU MR; JACQUES PF; SELHUB J; DWORKIN L; ROSENBERG IH
      ELEVATED FASTING TOTAL PLASMA HOMOCYSTEINE LEVELS AND CARDIOVASCULAR-DISEASE OUTCOMES IN MAINTENANCE DIALYSIS PATIENTS - A PROSPECTIVE-STUDY

      Arteriosclerosis, thrombosis, and vascular biology
    41. BOSTOM AG; GOHH RY; TSAI MY; HOPKINSGARCIA BJ; NADEAU MR; BIANCHI LA; JACQUES PF; ROSENBERG IH; SELHUB J
      EXCESS PREVALENCE OF FASTING AND POSTMETHIONINE-LOADING HYPERHOMOCYSTEINEMIA IN STABLE RENAL-TRANSPLANT RECIPIENTS

      Arteriosclerosis, thrombosis, and vascular biology
    42. BEAULIEU A; GOHH RY; HUME AL; PERRONE G; BOSTOM AG
      EFFECT OF VITAMIN-B6 SUPPLEMENTATION ON PLASMA-LIPIDS IN RENAL-TRANSPLANT RECIPIENTS

      Journal of the American Society of Nephrology
    43. BOSTOM AG; GOHH RY; BEAULIEU A; NADEAU MR; HUME AL; JACQUES PF; SELHUB J; ROSENBERG IH
      HOMOCYSTEINE-LOWERING TREATMENT OF RENAL-TRANSPLANT RECIPIENTS

      Journal of the American Society of Nephrology
    44. BOSTOM AG
      ELEVATED LIPOPROTEIN(A) AND PREMATURE CORONARY HEART-DISEASE - REPLY

      JAMA, the journal of the American Medical Association
    45. BOSTOM AG; LATHROP L
      HYPERHOMOCYSTEINEMIA IN END-STAGE RENAL-DISEASE - PREVALENCE, ETIOLOGY, AND POTENTIAL RELATIONSHIP TO ARTERIOSCLEROTIC OUTCOMES

      Kidney international
    46. BOSTOM AG
      ADJUNCTIVE DRUG-THERAPY FOR ACUTE MYOCARDIAL-INFARCTION

      The New England journal of medicine
    47. BOSTOM AG; MAYER J; GOHH RY; BEAULIEU A; NADEAU MR; HUME AL; JACQUES PF; SELHUB J; ROSENBERG IH
      HOMOCYSTEINE-LOWERING TREATMENT OF RENAL-TRANSPLANT RECIPIENTS

      Circulation
    48. BOSTOM AG; GOHH RY; BEAULIEU AJ; NADEAU MR; HUME AL; JACQUES PF; SELHUB J; ROSENBERG IH
      TREATMENT OF HYPERHOMOCYSTEINEMIA IN RENAL-TRANSPLANT RECIPIENTS - A RANDOMIZED, PLACEBO-CONTROLLED TRIAL

      Annals of internal medicine
    49. FISHER DH; BOSTOM AG
      TOTAL N-ACETYLCYSTEINE LEVELS ARE ELEVATED IN THE PLASMA OF PATIENTS WITH CHRONIC-RENAL-FAILURE

      Analytical letters
    50. SHEMIN D; BOSTOM AG; VERHOEF P; NADEAU M; JAQUES PF; SELHUB J; DWORKIN L; ROSENBERG IH
      PLASMA HOMOCYSTEINE (THCY) LEVELS AND MORTALITY IN DIALYSIS PATIENTS

      Journal of the American Society of Nephrology
    51. BOSTOM AG; SHEMIN D; CHAN J; LAPANE K; ROZEN R; NADEAU M; JACQUES P; SELHUB J
      FOLATE STATUS, A COMMON MUTATION IN METHYLENE-TETRAHYDROFOLATE REDUCTASE, AND FASTING TOTAL PLASMA HOMOCYSTEINE LEVELS IN DIALYSIS PATIENTS

      Journal of the American Society of Nephrology
    52. BOSTOM AG; SHEMIN D; LAPANE K; SUTHERLAND P; NADEAU M; WILSON PWF; BAUSSERMAN L; TOFLER G; JACQUES P; SELHUB J; ROSENBERG IH
      CONCORDANT ELEVATIONS IN PLASMA HOMOCYSTEINE, FIBRINOGEN, AND LIPOPROTEIN (A) IN DIALYSIS PATIENTS

      Journal of the American Society of Nephrology
    53. BOSTOM AG; CUPPLES LA; JENNER JL; ORDOVAS JM; SEMAN LJ; WILSON PWF; SCHAEFER EJ; CASTELLI WP
      ELEVATED PLASMA LIPOPROTEIN(A) AND CORONARY HEART-DISEASE IN MEN AGED55 YEARS AND YOUNGER - A PROSPECTIVE-STUDY

      JAMA, the journal of the American Medical Association
    54. BOSTOM AG; MAYER J
      FOLIC-ACID FORTIFICATION OF FOOD

      JAMA, the journal of the American Medical Association
    55. BOSTOM AG; SHEMIN D; LAPANE KL; HUME AL; YOBURN D; NADEAU MR; BENDICH A; SELHUB J; ROSENBERG IH
      HIGH-DOSE VITAMIN-B TREATMENT OF HYPERHOMOCYSTEINEMIA IN DIALYSIS PATIENTS

      Kidney international
    56. SELHUB J; JACQUES PF; BOSTOM AG; DAGOSTINO RB; WILSON PWF; BELANGER AJ; OLEARY DH; WOLF PA; RUSH D; SCHAEFER EJ; ROSENBERG IH
      RELATIONSHIP BETWEEN PLASMA HOMOCYSTEINE, VITAMIN STATUS AND EXTRACRANIAL CAROTID-ARTERY STENOSIS IN THE FRAMINGHAM-STUDY POPULATION

      The Journal of nutrition
    57. BOSTOM AG; SHEMIN D; LAPANE KL; SUTHERLAND P; NADEAU MR; WILSON PWF; YOBURN D; BAUSSERMAN L; TOFLER G; JACQUES PF; SELHUB J; ROSENBERG IH
      HYPERHOMOCYSTEINEMIA, HYPERFIBRINOGENEMIA, AND LIPOPROTEIN (A) EXCESSIN MAINTENANCE DIALYSIS PATIENTS - A MATCHED CASE-CONTROL STUDY

      Atherosclerosis
    58. BOSTOM AG; SHEMIN D; LAPANE KL; NADEAU MR; SUTHERLAND P; CHAN J; ROZEN R; YOBURN D; JACQUES PF; SELHUB J; ROSENBERG IH
      FOLATE STATUS IS THE MAJOR DETERMINANT OF FASTING TOTAL PLASMA HOMOCYSTEINE LEVELS IN MAINTENANCE DIALYSIS PATIENTS

      Atherosclerosis
    59. BOSTOM AG; SHEMIN D; YOBURN D; FISHER DH; NADEAU MR; SELHUB J
      LACK OF EFFECT OF ORAL N-ACETYLCYSTEINE ON THE ACUTE DIALYSIS-RELATEDLOWERING OF TOTAL PLASMA HOMOCYSTEINE IN HEMODIALYSIS-PATIENTS

      Atherosclerosis
    60. JACQUES PF; BOSTOM AG; SELHUB J; ROZEN R
      METHYLENETETRAHYDROFOLATE REDUCTASE MUTATION AND CORONARY-ARTERY DISEASE - RESPONSE

      Circulation
    61. BOSTOM AG; SHEMIN D; VERHOEF P; NADEAU M; JACQUES PF; SELHUB J; DWORKIN L; ROSENBERG IH
      TOTAL PLASMA HOMOCYSTEINE LEVELS AND OVERALL AND CARDIOVASCULAR-DISEASE (CVD)-SPECIFIC MORTALITY IN MAINTENANCE DIALYSIS PATIENTS

      Circulation
    62. BOSTOM AG; SHEMIN D; LAPANE K; BAUSSERMAN L; TOFLER G; WILSON PWF; SELHUB J; ROSENBERG IH
      HYPERHOMOCYSTEINEMIA, HYPERFIBRINOGENEMIA, AND LIPOPROTEIN(A) EXCESS IN MAINTENANCE DIALYSIS PATIENTS - A MATCHED, CASE-CONTROL STUDY

      Circulation
    63. JACQUES PF; BOSTOM AG; WILLIAMS RR; ELLISON RC; ECKFELDT JH; ROSENBERG IH; SELHUB J; ROZEN R
      RELATION BETWEEN FOLATE STATUS, A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE, AND PLASMA HOMOCYSTEINE CONCENTRATIONS

      Circulation
    64. BOSTOM AG
      METHIONINE LOADING, VITAMIN-B-6 STATUS, AND PREMATURE THROMBOEMBOLIC DISEASE

      Annals of internal medicine
    65. SHEMIN D; BOSTOM AG; LAPANE KL; SUTHERLAND P; NADEAU MR; WILSON PWF; SELHUB J; ROSENBERG IH
      HYPERHOMOCYSTEINEMIA IS MORE PREVALENT THAN THE TRADITIONAL CARDIOVASCULAR-DISEASE RISK-FACTORS IN DIALYSIS PATIENTS

      Journal of the American Society of Nephrology
    66. BROSNAN JT; HALL B; SELHUB J; NADEAU MR; BOSTOM AG
      RENAL METABOLISM OF HOMOCYSTEINE IN-VIVO

      Biochemical Society transactions
    67. BOSTOM AG; HUME AL; EATON CB; LAURINO JP; YANEK LR; REGAN MS; MCQUADE WH; CRAIG WY; PERRONE G; JACQUES PF
      THE EFFECT OF HIGH-DOSE ASCORBATE SUPPLEMENTATION ON PLASMA LIPOPROTEIN(A) LEVELS IN PATIENTS WITH PREMATURE CORONARY HEART-DISEASE

      Pharmacotherapy
    68. CRAIG WY; BOSTOM AG
      LIPOPROTEIN(A) CONCENTRATION AND RISK OF ATHEROTHROMBOTIC DISEASE

      JAMA, the journal of the American Medical Association
    69. SELHUB J; JACQUES PF; BOSTOM AG; DAGOSTINO RB; WILSON PWF; BELANGER AJ; OLEARY DH; WOLF PA; SCHAEFER EJ; ROSENBERG IH
      ASSOCIATION BETWEEN PLASMA HOMOCYSTEINE CONCENTRATIONS AND EXTRACRANIAL CAROTID-ARTERY STENOSIS

      The New England journal of medicine
    70. BOSTOM AG; JACQUES PF; NADEAU MR; WILLIAMS RR; ELLISON RC; SELHUB J
      POST-METHIONINE LOAD HYPERHOMOCYSTEINEMIA IN PERSONS WITH NORMAL FASTING TOTAL PLASMA HOMOCYSTEINE - INITIAL RESULTS FROM THE NHLBI FAMILY HEART-STUDY

      Atherosclerosis
    71. BOSTOM AG; SHEMIN D; LAPANE KL; MILLER JW; SUTHERLAND P; NADEAU M; SEYOUM E; HARTMAN W; PRIOR R; WILSON PWF; SELHUB J
      HYPERHOMOCYSTEINEMIA AND TRADITIONAL CARDIOVASCULAR-DISEASE RISK-FACTORS IN END-STAGE RENAL-DISEASE PATIENTS ON DIALYSIS - A CASE-CONTROL STUDY

      Atherosclerosis
    72. BOSTOM AG; SHEMIN D; NADEAU MR; SHIH V; STABLER SP; ALLEN RH; SELHUB J
      SHORT-TERM BETAINE THERAPY FAILS TO LOWER ELEVATED FASTING TOTAL PLASMA HOMOCYSTEINE CONCENTRATIONS IN HEMODIALYSIS-PATIENTS MAINTAINED ON CHRONIC FOLIC-ACID SUPPLEMENTATION

      Atherosclerosis
    73. BOSTOM AG; ROUBENOFF R; DELLARIPA P; NADEAU MR; SUTHERLAND P; WILSON PWF; JACQUES PF; SELHUB J; ROSENBERG IH
      VALIDATION OF ABBREVIATED ORAL METHIONINE-LOADING TEST

      Clinical chemistry
    74. BOSTOM AG; SHEMIN D; HUME AL; LAPANE KL; YOBURN D; NADEAU MR; BENDICH A; SELHUB J; ROSENBERG IH
      A RANDOMIZED TRIAL OF HIGH-DOSE VERSUS USUAL DOSE B-VITAMIN SUPPLEMENTATION FOR THE TREATMENT OF HYPERHOMOCYSTEINEMIA IN DIALYSIS PATIENTS

      Circulation
    75. SHEMIN D; GOHH RY; DWORKIN LD; BOSTOM AG; WILSON PWF; HARTMAN W; PRIOR R; SELHUB J
      PREVALENCE AND DETERMINANTS OF HYPERHOMOCYSTEINEMIA IN CHRONIC-RENAL-FAILURE

      Journal of the American Society of Nephrology
    76. BOSTOM AG
      LIPOPROTEIN(A) RISK IN WOMEN AND EFFICACY OF ASCORBATE

      JAMA, the journal of the American Medical Association
    77. BOSTOM AG; YANEK L; HUME AL; EATON CB; MCQUADE W; NADEAU M; PERRONE G; JACQUES PF; SELHUB J
      HIGH-DOSE ASCORBATE SUPPLEMENTATION FAILS TO AFFECT PLASMA HOMOCYST(E)INE LEVELS IN PATIENTS WITH CORONARY HEART-DISEASE

      Atherosclerosis
    78. BOSTOM AG; EATON CB; LAURINO JP; CRAIG WL; SELHUB J; CROWLEY J
      NONTRADITIONAL RISK-FACTORS FOR PREMATURE CORONARY HEART-DISEASE

      Circulation
    79. BOSTOM AG; EATON CB; LAURINO JP; CRAIG WL; SELHUB J; CROWLEY J
      NONTRADITIONAL RISK-FACTORS FOR PREMATURE CORONARY HEART-DISEASE

      Circulation
    80. SELHUB J; JACQUES PF; BOSTOM AG; DAGOSTINO R; WILSON PWF; WOLF PA; OLEARY DH; ROSENBERG IH
      HOMOCYSTEINEMIA PREDICTS PREVALENT CAROTID STENOSIS IN THE ELDERLY - THE FRAMINGHAM HEART-STUDY

      Circulation
    81. SELHUB J; JACQUES PF; BOSTOM AG; DAGOSTINO R; WILSON PWF; WOLF PA; OLEARY DH; ROSENBERG IH
      HOMOCYSTEINEMIA PREDICTS PREVALENT CAROTID STENOSIS IN THE ELDERLY - THE FRAMINGHAM HEART-STUDY

      Circulation
    82. BOSTOM AG; GAGNON DR; CUPPLES LA; WILSON PWF; JENNER JL; ORDOVAS JM; SCHAEFER EJ; CASTELLI WP
      A PROSPECTIVE INVESTIGATION OF ELEVATED LIPOPROTEIN(A) DETECTED BY ELECTROPHORESIS AND CARDIOVASCULAR-DISEASE IN WOMEN - THE FRAMINGHAM HEART-STUDY

      Circulation
    83. BOSTOM AG; GAGNON DR; CUPPLES LA; WILSON PWF; CASTELLI WP
      SINKING PREBETA LIPOPROTEIN PREDICTS INCIDENT CARDIOVASCULAR-DISEASE IN WOMEN - THE FRAMINGHAM HEART-STUDY

      Circulation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 00:40:17